Speaker: Meredith Bartelstein, MD, FAAOS, Memorial Sloan Kettering Cancer Center
For someone unfamiliar with sarcoma, what's the most important thing you want them to understand?
Meredith Bartelstein, MD, FAAOS: For someone unfamiliar with sarcoma, one of the most important things I want them to understand is that we have good, effective treatment available, and your doctor will help guide you through that entire process.
What's the biggest thing happening in sarcoma care right now? Is there an advance, a shift, or a challenge that stands out most?
Meredith Bartelstein, MD, FAAOS: One of the biggest things happening in sarcoma care right now is the push for us to work as teams, both multidisciplinary and across institutions, in order to improve upon our ability to treat this disease.
What's one thing you're watching closely right now that could reshape sarcoma care in the future?
Meredith Bartelstein, MD, FAAOS: I'm keeping an eye on long-term outcomes for our patients who are surviving sarcoma. Things like functional outcomes, psychosocial health; those are things I want to target. The short term is important, but I want to make sure we're anticipating and preparing for challenges that can come in the future.
What would you say to a colleague who's on the fence about joining the MsTR? What's the biggest benefit for sites and patients?
Meredith Bartelstein, MD, FAAOS: Sarcoma is a rare disease. We can learn more and do better for our patients when we work together.